M Jouve

2.1k total citations
49 papers, 1.6k citations indexed

About

M Jouve is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, M Jouve has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 16 papers in Cancer Research. Recurrent topics in M Jouve's work include Cancer Treatment and Pharmacology (18 papers), Breast Cancer Treatment Studies (15 papers) and Lung Cancer Treatments and Mutations (7 papers). M Jouve is often cited by papers focused on Cancer Treatment and Pharmacology (18 papers), Breast Cancer Treatment Studies (15 papers) and Lung Cancer Treatments and Mutations (7 papers). M Jouve collaborates with scholars based in France, United Kingdom and Belgium. M Jouve's co-authors include P Pouillart, T Palangié, Thierry Dorval, Philippe Beuzeboc, Bernard Asselain, Suzy Scholl, Jean‐Yves Pierga, J.C. Durand, Alain Fourquet and E García-Giralt and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

M Jouve

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Jouve France 16 983 964 569 262 258 49 1.6k
N. Pavlidis Greece 14 736 0.7× 894 0.9× 422 0.7× 442 1.7× 238 0.9× 38 1.5k
M. Tubiana-Hulin France 14 1.2k 1.2× 987 1.0× 570 1.0× 241 0.9× 316 1.2× 40 1.8k
J.L. Peterse Netherlands 21 1.1k 1.1× 921 1.0× 785 1.4× 172 0.7× 244 0.9× 42 1.7k
Fred C. Ames United States 8 1.3k 1.3× 845 0.9× 772 1.4× 118 0.5× 378 1.5× 8 1.6k
Frank J. Cummings United States 14 480 0.5× 444 0.5× 358 0.6× 136 0.5× 219 0.8× 30 1.0k
T Palangié France 15 877 0.9× 801 0.8× 446 0.8× 159 0.6× 181 0.7× 62 1.3k
E. Bourstyn France 12 637 0.6× 503 0.5× 358 0.6× 124 0.5× 246 1.0× 30 1.1k
Nurten Gündüz United States 12 692 0.7× 760 0.8× 259 0.5× 355 1.4× 312 1.2× 14 1.4k
Verena Hug United States 16 688 0.7× 767 0.8× 345 0.6× 186 0.7× 131 0.5× 44 1.4k
Christian Borel France 23 494 0.5× 1.2k 1.3× 324 0.6× 496 1.9× 433 1.7× 78 1.9k

Countries citing papers authored by M Jouve

Since Specialization
Citations

This map shows the geographic impact of M Jouve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Jouve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Jouve more than expected).

Fields of papers citing papers by M Jouve

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Jouve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Jouve. The network helps show where M Jouve may publish in the future.

Co-authorship network of co-authors of M Jouve

This figure shows the co-authorship network connecting the top 25 collaborators of M Jouve. A scholar is included among the top collaborators of M Jouve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Jouve. M Jouve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferlicot, Sophie, Anne Vincent‐Salomon, Jacques Médioni, et al.. (2003). Wide metastatic spreading in infiltrating lobular carcinoma of the breast. European Journal of Cancer. 40(3). 336–341. 149 indexed citations
2.
Pierga, Jean‐Yves, E Mouret, Valérie Laurence, et al.. (2003). Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. European Journal of Cancer. 39(8). 1089–1096. 63 indexed citations
3.
Pierga, Jean‐Yves, Mathieu Robain, M Jouve, et al.. (2001). Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients. Annals of Oncology. 12(2). 231–238. 29 indexed citations
4.
Pierga, J-Y, E Mouret, Véronique Dièras, et al.. (2000). Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer. British Journal of Cancer. 83(11). 1480–1487. 104 indexed citations
5.
Robain, Mathieu, Jean‐Yves Pierga, M Jouve, et al.. (2000). Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer. European Journal of Cancer. 36(18). 2301–2312. 16 indexed citations
6.
Braud, A.C., Bernard Asselain, Suzy Scholl, et al.. (1999). Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?. European Journal of Cancer. 35(3). 392–397. 13 indexed citations
7.
Pierga, J-Y, M Jouve, Bernard Asselain, et al.. (1998). Randomized trial comparing protracted infusion of 5-fluorouracil with weekly doxorubicin and cyclophosphamide with a monthly bolus FAC regimen in metastatic breast carcinoma (SPM90). British Journal of Cancer. 77(9). 1474–1479. 9 indexed citations
8.
Scholl, Suzy, Philippe Beuzeboc, Adrian L. Harris, et al.. (1998). Is Primary Chemotherapy Useful for All Patients with Primary Invasive Breast Cancer?. Recent results in cancer research. 152. 217–226. 7 indexed citations
9.
Pierga, J-Y, Philippe Beuzeboc, Thierry Dorval, et al.. (1997). Phase II Trial of Doxorubicin, 5-Fluorouracil, Etoposide, and Cisplatin in Advanced or Recurrent Endometrial Carcinoma. Gynecologic Oncology. 66(2). 246–249. 12 indexed citations
10.
García-Giralt, E, Philippe Beuzeboc, Véronique Dièras, et al.. (1996). Phase II Trial of Decapeptyl (D-TRP-6), a Potent Luteinizing Hormone-Releasing Hormone Analogue in Untreated Advanced Breast Cancer. American Journal of Clinical Oncology. 19(5). 455–458. 6 indexed citations
11.
Pierga, J-Y, Véronique Dièras, Thierry Dorval, et al.. (1996). Treatment of Advanced or Recurrent Endometrial Carcinoma with Combination of Etoposide, Cisplatin, and 5-Fluorouracil: A Phase II Study. Gynecologic Oncology. 60(1). 59–63. 14 indexed citations
12.
Scholl, Suzy, Jean‐Yves Pierga, Bernard Asselain, et al.. (1995). Breast tumour response to primary chemotherapy predicts local and distant control as well as survival. European Journal of Cancer. 31(12). 1969–1975. 133 indexed citations
13.
Palangié, T, Véronique Mosseri, J. Mihura, et al.. (1994). Prognostic factors in inflammatory breast cancer and therapeutic implications. European Journal of Cancer. 30(7). 921–927. 70 indexed citations
14.
Scholl, Suzy, Alain Fourquet, Bernard Asselain, et al.. (1994). Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6. European Journal of Cancer. 30(5). 645–652. 337 indexed citations
15.
Remvikos, Yorghos, et al.. (1993). Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspirates. European Journal of Cancer. 29(13). 1843–1848. 42 indexed citations
16.
Brunin, F, Juan Carlos de Vicente, C Jaulerry, et al.. (1992). [Role of neoadjuvant chemotherapy in the treatment of advanced head and neck tumors. Results of two randomized therapeutical trials conducted at the Institut Curie on 208 patients].. PubMed. 79(9). 893–904. 3 indexed citations
17.
Sastre‐Garau, Xavier, M. Lacombe, M Jouve, M. Véron, & H Magdelénat. (1992). Nucleoside diphosphate kinase/NM23 expression in breast cancer: Lack of correlation with lymph‐node metastasis. International Journal of Cancer. 50(4). 533–538. 90 indexed citations
18.
Jaulerry, C, José Rodríguez, F Brunin, et al.. (1992). Induction chemotherapy in advanced head and neck tumors: Results of two randomized trials. International Journal of Radiation Oncology*Biology*Physics. 23(3). 483–489. 64 indexed citations
19.
Scholl, Suzy, Bernard Asselain, T Palangié, et al.. (1991). Neoadjuvant chemotherapy in operable breast cancer. European Journal of Cancer and Clinical Oncology. 27(12). 1668–1671. 82 indexed citations
20.
Jouve, M, T Palangié, L Belli, et al.. (1989). [Metastatic breast cancer. Chemotherapy with adriamycin, vindesine, cyclophosphamide and 5 FU. Value of continuous 5 FU perfusion. Results of controlled trials].. PubMed. 76(6). 643–52. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Pavlidis Breakdown of academic impact, for papers by M. Tubiana-Hulin Breakdown of academic impact, for papers by J.L. Peterse Breakdown of academic impact, for papers by Fred C. Ames Breakdown of academic impact, for papers by Frank J. Cummings Breakdown of academic impact, for papers by T Palangié Breakdown of academic impact, for papers by E. Bourstyn Breakdown of academic impact, for papers by Nurten Gündüz Breakdown of academic impact, for papers by Verena Hug Breakdown of academic impact, for papers by Christian Borel
Rankless by CCL
2026